The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study — Stella

Recruiting

Back to Takotsubo Cardiomyopathy trials

Trial locations(1 site)

United States

Cedars Sinai Medical Center, Los Angeles, California

Key details

Sponsor

Cedars-Sinai Medical Center

Enrollment target

~1,000 participants

Started

February 2019

Primary completion

February 2029

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov